https://www.selleckchem.com/GSK-3.html
Overall pooled results showed that WMB interventions' effects on decreasing anxiety (SMD - 0.20, - 0.45 to 0.05, I = 72%), depression (SMD - 0.10, - 0.30 to 0.11, I = 73%), and distress (SMD - 0.20, - 0.47 to 0.06, I = 60%) were not significant for randomized controlled trials (RCTs). In contrast, WMB interventions significantly decreased symptoms of anxiety (p = .002) in a sub-group analysis of non-RCTs. This meta-analysis demonstrated that WMB interventions were not efficacious in alleviating emotional symptoms in adults with advanced cancer.
Gefällt mir
Kommentar
Teilen
